A. Lesoin

发表

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.

I. Ray-Coquard, D. Berton‐Rigaud, F. Selle, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.

O. Trédan, F. Gernier, E. Kalbacher, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and dose modification for patients receiving niraparib

J. Ledermann, J. Berek, I. Vergote, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.

D. Berton, F. Guyon, N. Radosevic-Robin, 2020, Gynecologic oncology.

Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy.

V. Gebski, M. Friedlander, R. Largillier, 2019, European journal of cancer.

[Functional MR Imaging: new tool to predict outcome for cervical carcinoma of uterus treated by concomitant radiochemotherapy?].

F. Narducci, L. Ceugnart, P. Nickers, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.

F. Mayer, P. Morice, P. Kerbrat, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.

L. weiswald, A. Leary, E. Kalbacher, 2022, Gynecologic oncology.

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

B. Monk, A. Oza, R. Wenham, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma.

C. Fournier, B. Castelain, D. Querleu, 2007, Gynecologic oncology.

A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant therapy in patients with FIGO stage IIIc/IV ovarian, tubal, or peritoneal adenocarcinoma, initially unresectable.

R. Rouzier, F. Guyon, P. Colombo, 2014 .

Surgical staging of early invasive epithelial ovarian tumors.

D. Querleu, E. Leblanc, F. Narducci, 2000, Seminars in surgical oncology.

Uterine papillary serous carcinoma

V. Samouëlian, M. Baranzelli, A. Lesoin, 2009 .

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

N. Penel, A. Adenis, É. Dansin, 2018, BMC Cancer.

Présentation inhabituelle d'un choriocarcinome gestationnel

C. Régis, S. Taïeb, M. Baranzelli, 2006 .

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

K. Venkatakrishnan, R. Kurzrock, I. Ray-Coquard, 2019, JAMA oncology.

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group

I. Treilleux, I. Ray-Coquard, E. Kalbacher, 2017, British Journal of Cancer.

Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.

E. Blot, I. Ray-Coquard, E. Kalbacher, 2019, Gynecologic oncology.

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

B. Monk, C. Schade-Brittinger, R. Kimmig, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup

A. Jimeno, D. Katsaros, I. Vergote, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Hypercalcemia and squamous cell carcinoma of the upper respiratory-digestive tracts. Incidence and prognosis].

C. Fournier, M. Nguyen, J. Lefebvre, 1995, Bulletin du cancer.

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.

O. Trédan, F. Gernier, E. Kalbacher, 2019 .

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

A. Italiano, J. Bonneterre, M. Campone, 2018, PloS one.

[Management of pregnant women with advanced cervical cancer: About five cases observed in Lille from 2002 till 2009. Evaluation of practices referring to the new French recommendations of 2008].

D. Vinatier, B. Castelain, P. Collinet, 2011, Journal de gynecologie, obstetrique et biologie de la reproduction.

Prolactin Receptors and Lactalbumin Plasma Production in Human Breast Cancer

J. Lefebvre, B. Vandewalle, A. Lesoin, 1986 .

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy

B. Monk, M. King, M. Friedlander, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.

R. Rouzier, P. Colombo, E. Kalbacher, 2017, European journal of cancer.

Safety and dose modification for patients receiving niraparib.

J. Berek, I. Vergote, S. Ellard, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Onapristone (ONA) in progesterone receptor (PR)-expressing tumors: Efficacy and biomarker results of a dose-escalation phase 1 study.

A. Italiano, J. Bonneterre, M. Campone, 2015 .

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.

B. Weber, I. Vergote, J. Šufliarský, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

973PA GINECO phase II study of Navitoclax (ABT 263) in women with platinum resistant/refractory recurrent ovarian cancer (ROC)

A. Leary, E. Kalbacher, A. Floquet, 2017 .

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

A. Reuss, I. Ray-Coquard, N. Colombo, 2019, International journal of cancer.

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

N. Penel, A. Adenis, É. Dansin, 2018, BMC Cancer.

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

B. Monk, C. Schade-Brittinger, R. Kimmig, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report.

B. Castelain, T. Lacornerie, F. Narducci, 2015, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

A. Jimeno, D. Katsaros, I. Ray-Coquard, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Neurologic manifestations of spinal plasmacytomas].

J. Bonneterre, M. Jomin, F. Lesoin, 1982, Neuro-Chirurgie.